Cargando…
Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288781/ https://www.ncbi.nlm.nih.gov/pubmed/35429120 http://dx.doi.org/10.1002/ehf2.13929 |
_version_ | 1784748524322160640 |
---|---|
author | Girerd, Nicolas Von Hunolstein, Jean‐Jacques Pellicori, Pierpaolo Bayés‐Genís, Antoni Jaarsma, Tiny Lund, Lars H. Bilbault, Pascal Boivin, Jean‐Marc Chouihed, Tahar Costa, Jérôme Eicher, Jean‐Christophe Fall, Estelle Kenizou, David Maillier, Bruno Nazeyrollas, Pierre Roul, Gérald Zannad, Noura Rossignol, Patrick Seronde, Marie‐France |
author_facet | Girerd, Nicolas Von Hunolstein, Jean‐Jacques Pellicori, Pierpaolo Bayés‐Genís, Antoni Jaarsma, Tiny Lund, Lars H. Bilbault, Pascal Boivin, Jean‐Marc Chouihed, Tahar Costa, Jérôme Eicher, Jean‐Christophe Fall, Estelle Kenizou, David Maillier, Bruno Nazeyrollas, Pierre Roul, Gérald Zannad, Noura Rossignol, Patrick Seronde, Marie‐France |
author_sort | Girerd, Nicolas |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9288781 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92887812022-07-19 Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction Girerd, Nicolas Von Hunolstein, Jean‐Jacques Pellicori, Pierpaolo Bayés‐Genís, Antoni Jaarsma, Tiny Lund, Lars H. Bilbault, Pascal Boivin, Jean‐Marc Chouihed, Tahar Costa, Jérôme Eicher, Jean‐Christophe Fall, Estelle Kenizou, David Maillier, Bruno Nazeyrollas, Pierre Roul, Gérald Zannad, Noura Rossignol, Patrick Seronde, Marie‐France ESC Heart Fail Editorial John Wiley and Sons Inc. 2022-04-15 /pmc/articles/PMC9288781/ /pubmed/35429120 http://dx.doi.org/10.1002/ehf2.13929 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Editorial Girerd, Nicolas Von Hunolstein, Jean‐Jacques Pellicori, Pierpaolo Bayés‐Genís, Antoni Jaarsma, Tiny Lund, Lars H. Bilbault, Pascal Boivin, Jean‐Marc Chouihed, Tahar Costa, Jérôme Eicher, Jean‐Christophe Fall, Estelle Kenizou, David Maillier, Bruno Nazeyrollas, Pierre Roul, Gérald Zannad, Noura Rossignol, Patrick Seronde, Marie‐France Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction |
title | Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction |
title_full | Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction |
title_fullStr | Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction |
title_full_unstemmed | Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction |
title_short | Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction |
title_sort | therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288781/ https://www.ncbi.nlm.nih.gov/pubmed/35429120 http://dx.doi.org/10.1002/ehf2.13929 |
work_keys_str_mv | AT girerdnicolas therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction AT vonhunolsteinjeanjacques therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction AT pellicoripierpaolo therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction AT bayesgenisantoni therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction AT jaarsmatiny therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction AT lundlarsh therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction AT bilbaultpascal therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction AT boivinjeanmarc therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction AT chouihedtahar therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction AT costajerome therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction AT eicherjeanchristophe therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction AT fallestelle therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction AT kenizoudavid therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction AT maillierbruno therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction AT nazeyrollaspierre therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction AT roulgerald therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction AT zannadnoura therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction AT rossignolpatrick therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction AT serondemariefrance therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction AT therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction |